Insys Therapeutics to take part in claim analysis protocol mediation

By Caroline Salls

Pittsburgh, Oct. 23 – A mediator has been appointed for Insys Therapeutics Inc.’s Chapter 11 case to help resolve issues surrounding a claims analysis protocol, according to an order filed Wednesday with the U.S. Bankruptcy Court for the District of Delaware.

Eric D. Greene has been appointed as mediator.

In addition to the company, the official committee of unsecured creditors appointed for Insys’s case, as well as a multi-district litigation executive committee and representatives of some state governments will participate in the one-day mediation session.

The specialty pharmaceutical company is based in Phoenix. The company filed bankruptcy on June 10 under Chapter 11 case number 19-11292.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.